Digest Network Come funziona
Network
/
Società
Om
Non verificato

OmniAb, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteScienzaWeb e Social Network

31 comunicati stampa

Guarda tutti i comunicati
24/04/2026
Eventi
Finanza
Industria
Biotecnologia
Farmaceutica
Salute
OmniAb to Participate in Three Upcoming Investor Conferences
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0
21/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Salute
Scienza
Farmaceutica
OmniAb to Report First Quarter 2026 Financial Results on May 7
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0
04/03/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0
24/02/2026
Eventi
Industria
Biotecnologia
Salute
Scienza
Farmaceutica
OmniAb to Participate at the Leerink Partners Global Healthcare Conference
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0
19/02/2026
Biotecnologia
Salute
Scienza
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
OmniAb to Report Fourth Quarter 2025 Financial Results on March 4
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0
15/12/2025
Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0
04/12/2025
Web e Social Network
Eventi
Industria
Biotecnologia
Salute
Scienza
Farmaceutica
OmniAb to Hold OmniUltra Virtual Investor Event on December 15
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0
17/11/2025
Mercato del lavoro
Associazioni/Professionisti
Salute
Finanza
Farmaceutica
Biotecnologia
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0
04/11/2025
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0
16/10/2025
Biotecnologia
Farmaceutica
Salute
Eventi
OmniAb to Participate in Three Investor Conferences in November
Fonte
OmniAb, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0